Results
Molbio posts Rs 1,020 crore FY25 revenue
By Abha Lohia · Editor ·
Molbio Diagnostics: revenue and funding and every story →
Goa
- Molbio Diagnostics reported revenue of about Rs 1,020 crore for FY25, the year ended March 2025
- Profit after tax (net profit once all costs and taxes are paid) for the year came to Rs 138 crore
- That is a net margin of roughly 13.5 per cent, or about Rs 13.5 of profit for every Rs 100 of sales
What happened
- Revenue for FY25 was about Rs 1,020 crore.
- Profit after tax was Rs 138 crore.
- The figures were reported in September 2025, as the IPO process was under way.
The numbers around it
Molbio Diagnostics has 1 funding rounds in StopDown's archive.
| When | Round | Amount | Led by |
|---|---|---|---|
| 7 August 2026 | Pre-IPO anchor round | ₹281.5 Cr | Undefined |
Terms in this story
- Financial year: An Indian financial year runs from 1 April to 31 March, and it is named after the year it ends. FY26 means April 2025 to March 2026. Startup results for a year arrive months after it closes, so a November 2026 story may still be about FY25.
Read next
Everything on Molbio Diagnostics → · All startup news on 1 September 2025 →
Is this Molbio Diagnostics? Get your “Featured on StopDown” badge →